Share this article:

Take double-digit gains on Vanda Pharmaceuticals (VNDA)

Today's Financial News - Posted January 23, 2009

Time to take sleepy-time gains off the table!

by Laura Cadden

Baltimore (TFN): On December 2, we recommended TFN readers buy shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) in anticipation of success with its VEC-162 drug for the treatment of sleeping disorders.

The stock share price had been battered down to below 60 cents at that time — from a 52-week high of $6.50!

Today, the stock has hit 81 cents, giving those that got in under my recommended buy price of 75 cents the anticipated double-digit gains.

For those that got in that day at 60 cents — the gains are over 35%!

Let’s take ‘em!

I recommend you sell your shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA).

Next Article: Who’s winning the currency paralympics?

Upcoming FDA decision dates… and the companies that may benefit - December 30, 2009
22% gains on Seattle Genetics, Inc. (SGEN) - August 26, 2009
Cerus Corporation (CERS) soars on Swiss approval: HSC members take 53.7% gains in 15 days - August 19, 2009
HSC gainer #67: Arotech Corporation (ARTX) bunkers 21.6% - October 12, 2009
Curis Inc. (CRIS) is up on buy-out rumors: We say Hold! - August 28, 2009

Posted by J. Christoph Amberger · Filed Under US Stocks and Markets

Share this article:

Be the first to leave a reply.

Your comments are welcome

Follow TFN via RSS or Twitter

<a href='http://www.todaysfinancialnews.com/tfn-ads/www/delivery/ck.php?n=a362353e&cb={random}' target='_blank'><img src='http://www.todaysfinancialnews.com/tfn-ads/www/delivery/avw.php?zoneid=12&source=IL&cb={random}&n=a362353e&ct0={clickurl}' border='0' alt='' /></a>
Advertisement

Today’s Financial News - For the Capitalist in all of us

Take double-digit gains on Vanda Pharmaceuticals (VNDA)

Related Articles

Be the first to leave a reply.

Latest Headlines

Topics